|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 2, 340-346, Copyright © 1988 by European Association for Cardio-thoracic Surgery
A Arvay and M Lengyel
To study the incidence and risk factors of prosthetic valve endocarditis
(PVE) we followed 99.5% of 912 patients who had valve replacements from 1
January 1981 to 31 December 1985 for 1-6 (mean 3) years. PVE occurred in 27
patients (2.96% or 0.98% per patient-year). The incidence of PVE in the
aortic position (3.9%) was significantly higher than in the mitral position
(1.5%): chi-square = 6.1, P less than 0.025. PVE developed in 19 of 329
patients with bioprostheses (5.8%), and in 8 of 583 patients with
mechanical valves (1.4%): chi- square = 14.48, P less than 0.005).
Actuarially at 5-year follow-up, 90.7% +/- 2.16% of the bioprosthetic group
and 98.4% +/- 0.56% of the mechanical valve group was free of PVE (P less
than 0.001). Antecedent endocarditis increased both the incidence and
relative risk of PVE 7- fold compared to patients without antecedent
endocarditis (chi-square = 32.0, P less than 0.0001). Bioprosthetic valve
replacement in infective endocarditis increased the risk of PVE 12-fold
compared to valve replacement by mechanical prostheses. In conclusion: in
the order of importance, antecedent endocarditis, bioprostheses and aortic
position are risk factors in the development of PVE. Bioprostheses
implanted in patients with antecedent endocarditis further enhance the risk
of PVE.
ARTICLES
Incidence and risk factors of prosthetic valve endocarditis
Hungarian Institute of Cardiology, Budapest.
This article has been cited by other articles:
![]() |
M. C. Farinas, A. Perez-Vazquez, C. Farinas-Alvarez, J. D. Garcia-Palomo, J. M. Bernal, J. M. Revuelta, and J. Gonzalez-Macias Risk Factors of Prosthetic Valve Endocarditis: A Case-Control Study Ann. Thorac. Surg., April 1, 2006; 81(4): 1284 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Siniawski, O. Grauhan, M. Hofmann, M. Pasic, Y. Weng, C. Yankah, H. Lehmkuhl, and R. Hetzer Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 434 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Filsoufi and D. H. Adams Surgical Treatment of Mitral Valve Endocarditis Card. Surg. Adult, January 1, 2003; 2(2003): 987 - 997. [Full Text] |
||||
![]() |
D. R. Clarke Presidential address: Value, viability, and valves J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 1 - 6. [Full Text] [PDF] |
||||
![]() |
E. Mylonakis and S. B. Calderwood Infective Endocarditis in Adults N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330. [Full Text] [PDF] |
||||
![]() |
A. M. Safi, T. Kwan, E. Afflu, A. Al Kamme, and L. Salciccioli Paravalvular Regurgitation: A Rare Complication Following Valve Replacement Surgery Angiology, June 1, 2000; 51(6): 479 - 487. [Abstract] [PDF] |
||||
![]() |
C. Alexiou, S. M. Langley, H. Stafford, J. A. Lowes, S. A. Livesey, and J. L. Monro Surgery for active culture-positive endocarditis: determinants of early and late outcome Ann. Thorac. Surg., May 1, 2000; 69(5): 1448 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Grover, D. J. Cohen, C. Oprian, W. G. Henderson, G. Sethi, K. E. Hammermeister, and Participants in the Department of Veterans Affairs Determinants of the occurrence of and survival from prosthetic valve endocarditisExperience of the Veterans Affairs Cooperative Study on Valvular Heart Disease J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 207 - 214. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |